Time to death predictors of HIV/AIDS infected patients on antiretroviral therapy in Ethiopia.
Melaku TadegePublished in: BMC research notes (2018)
From the Kaplan-Meier, log-rank test result indicated that there was a significant difference between tuberculosis comorbidity (P = .000), occupation (P = .027), and WHO clinical stage (P = .012) on the survival experience of patients at 5% statistical significance level. From the Cox regression result, the risk of death for patients who lived with tuberculosis was about 2.872-fold times higher than those patients who were negative. Most of the HIV/AIDS patients on antiretroviral therapy were died in a short period due to tuberculosis comorbidity, began with lower amount of CD4, being underweight, merchant, and being on WHO clinical stage IV.
Keyphrases
- hiv aids
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- hiv infected patients
- hiv positive
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- peritoneal dialysis
- mycobacterium tuberculosis
- emergency department
- pulmonary tuberculosis
- patient reported outcomes
- men who have sex with men
- adverse drug
- nk cells